Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Eken Dermatologi AB
AB
Active
Org 5591026884
Linnégatan 77, 114 60
Stockholm
General medical practice activities
· NACE 8621
Est. 2017
0 employees
Watchlist
Share
Sweden
/
Companies
/
General medical practice activities
/
Eken Dermatologi AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
0
0
0
317
366
Staff expenses
—
—
—
−5
−0
EBITDA
−5
−1
11
190
145
Depreciation & amort.
−0
−0
−0
—
−51
EBIT
−5
−1
11
190
94
Net financials
—
—
—
0
0
Profit before tax
−5
−1
11
190
94
Tax
−0
−0
−2
−39
−19
Net profit
−5
−1
9
151
75
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
117
112
61
255
417
Equity
113
112
59
210
285
Long-term debt
0
0
0
—
—
Short-term debt
4
0
2
45
132
Total debt
4
—
2
45
132
Financial ratios
5-year trend
EBITDA margin
39.6%
This company
15.8%
Market median
+151% vs market
2021
2025
Equity ratio
68.3%
This company
38.2%
Market median
+79% vs market
2021
2025
Return on equity
26.2%
This company
18.4%
Market median
+42% vs market
2021
2025
Net profit margin
20.4%
This company
8.1%
Market median
+152% vs market
2021
2025
Asset turnover
0.88×
This company
1.12×
Market median
+21% vs market
2021
2025
Debt / equity
0.46×
This company
0.62×
Market median
+26% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
More on Eken Dermatologi AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
